Dr. Vadym V. Rusnak, MD

Dr. Rusnak practices at River Parishes Dialysis in Kenner, Louisiana.

Dr. Rusnak's NPI, 1093100026, was assigned on April 6, 2015. Dr. Rusnak holds Louisiana license 207RN0300X.

Dr. Rusnak's primary practice is River Parishes Dialysis, at 200 W Esplanade Ave, Kenner, LA 70065 in Jefferson Parish. The practice phone is (985) 603-7160.

Dr. Rusnak's primary practice is River Parishes Dialysis in Kenner, Louisiana. Dr. Rusnak is also affiliated with Ochsner Medical Center - Kenner. The medical group on file is Kidney Consultants LLC. Dmand AI also links Dr. Rusnak to 1 more hospital, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rusnak practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rusnak's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rusnak is licensed in Louisiana.

CMS data shows 1,152 Medicare services from Dr. Rusnak across 6 procedure codes in 2024, for 150 Medicare patients. Medicare paid $114,884 for them.

CMS counts 150 Medicare patients who saw Dr. Rusnak in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 5.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rusnak's median patient age at 67, with 52% women.

In 2024, Dr. Rusnak wrote 105 Medicare Part D claims for 21 patients. 98% of them were for generic drugs. CMS names the drug for 67 of them, across 4 drugs with 11 or more claims each, at $3,970 in total drug cost. In 2023, CMS named 118 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rusnak for performance year 2024, reported as part of a group. Dr. Rusnak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Rusnak, published from 2017 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Attitude of Health Personnel, Clinical Competence and High Fidelity Simulation Training.

CMS Open Payments shows 64 general payments to Dr. Rusnak from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $685.